本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CG Oncology Inc.

27.97
+5.6025.03%
盤後27.86-0.1098-0.39%17:25 EDT
成交量:894.52萬
成交額:2.65億
市值:21.32億
市盈率:-19.86
高:32.30
開:31.00
低:27.57
收:22.37
資料載入中...
2024/07/22

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/03

重要事件披露

Form 8-K - Current report
2024/04/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/18

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/05

SEC問詢函

Form CORRESP - Correspondence